Rapid Micro Biosystems (NASDAQ:RPID)報告季度每股虧損$(0.22)，優於分析師普遍預期的$(0.23)，增長了4.35%。這相比去年同期每股虧損$(0.26)增加了15.38%。公司報告季度銷售額爲822萬美元，超出分析師普遍預期的780萬美元，增長了5.36%。這比去年同期634萬美元的銷售額增長了29.68%。

以上內容來自Benzinga Earnings專欄，原文如下：

Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.22 million which beat the analyst consensus estimate of $7.80 million by 5.36 percent. This is a 29.68 percent increase over sales of $6.34 million the same period last year.